Bustamante, Ricardo, SR.. .

HRN: 17-88-40  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2025
CEFTRIAXONE 1G (VIAL)
12/26/2025
01/02/2026
IV
2g
Od
TYPHOID FEVER
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines